Olga Kubassova, PhD[email protected]Nuclear MedicineHow medical imaging can accelerate drug developmentIt can take 15 years to get a drug candidate from the lab to approval. Could medical imaging speed up that process? Olga Kubassova, PhD, of Image Analysis Group explains how imaging modalities such as MRI, CT, and PET are helping to track biomarkers in clinical studies, potentially bringing lifesaving therapies to patients more quickly.January 21, 2019Page 1 of 1Top StoriesMolecular ImagingAmyloid PET scans validated in racially diverse patientsChanges in care plans occurred in 59% of individuals after PET scans.Womens ImagingLimited access to PCPs thwarts mammography screening uptakeUltrasoundPOCUS rules out pulmonary congestion in kidney patientsEconomicsLow-value imaging services part of high Medicare costsDigital X-RayAI helps clinicians identify misplaced endotracheal tubes
